Had a great night supporting cancer research with @conquercancer.bsky.social

Grateful for the opportunity to partner with this cast of characters (missed you Fumiko!) to support an ASCO Young Investigator Award for Health Services Research for next year… and for the excellent party hosted by @conquercancer.bsky.social

Delighted to share our work finding #ePRO based remote symptom monitoring reduces hospitalizations in real-world oncology settings jamanetwork.com/journals/jam...

One of the best parts about this career is that your colleagues become your good friends.

Including #ePROs in multidisciplinary tumor board for patients with #cancer dramatically increases patient-centricity of discussions www.sciencedirect.com/science/arti...

System-Level Transformations to Increase Patient Participation in Clinical Trials. ascopubs.org/doi/10.1200/... @ascocancer.bsky.social @grocquemd.bsky.social #Cancer #ClinicalTrials #CancerResearch

#SABCS24: 957 pts w low risk #DCIS randomized to receive “guideline-concordant care” vs active monitoring 🗝️ points @2 yrs: 1️⃣Non inferior for dx invasive #breastCancer (!!!) 2️⃣"Lived Experience” similar, QOL/anxiety not worse 3️⃣Most got ET but only 55% in GCC got surg jamanetwork.com/journals/jam...

Beautiful work by Dr. Ann Partridge at #SABCS, #PRO outcomes (quality of life, anxiety, depression) were similar in patients having active monitoring for DCIS vs surgery up front.

It is critical to understand clinical team perspectives on #ePRO implementation

Impressive results of imluminestrant + abamacilib in context of other trials, by Hal Burstein at #SABCS

For multi cancer detection tests, understanding profiles of patients will be inportant for equitable screening. #AcademyHealth #D&I meeting.

Grateful to be able to celebrate 1 year of #navigation code availability as part of the Moonshot Initiative at the White House today. Proud of the UAB navigation team and all their work in this space!